Pharmacology and clinical use of foscarnet
Authors:
- Dominique Salmon-CéronDSDominique Salmon-Céron
- 1 July 1995
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 5 (4) , 209-217
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDSThe Lancet, 1992
- Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus RetinitisNew England Journal of Medicine, 1992
- Foscarnet for Treatment of Cytomegalovirus Infections in Bone Marrow Transplant RecipientsScandinavian Journal of Infectious Diseases, 1992
- Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnetAIDS, 1991
- FoscarnetDrugs, 1991
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989
- Foscarnet Nephrotoxicity: Mechanism, Incidence and PreventionAmerican Journal of Nephrology, 1989
- Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitisJournal of Medical Virology, 1988
- Treatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)The Journal of Infectious Diseases, 1988
- Reversible Inhibition of Cytomegalovirus Replication by PhosphonoformateIntervirology, 1980